155 related articles for article (PubMed ID: 37073462)
1. Kai-Xin-San Improves Cognitive Impairment via Wnt/β-Catenin and IRE1/XBP1s Signalings in APP/PS1 Mice.
Xu YM; Lu FM; Xu HC; Zhang J; Hei SY; Qiu YH; Cai YF; Zhang SJ; Zhao M
Rejuvenation Res; 2023 Jun; 26(3):105-115. PubMed ID: 37073462
[TBL] [Abstract][Full Text] [Related]
2. Classic Famous Prescription Kai-Xin-San Ameliorates Alzheimer's Disease via the Wnt/β-Catenin Signaling Pathway.
Shan X; Lv S; Huang P; Zhang W; Jin C; Liu Y; Li Y; Jia Y; Chu X; Peng C; Zhang C
Mol Neurobiol; 2024 Apr; 61(4):2297-2312. PubMed ID: 37874481
[TBL] [Abstract][Full Text] [Related]
3. Kai-Xin-San ameliorates Alzheimer's disease-related neuropathology and cognitive impairment in APP/PS1 mice via the mitochondrial autophagy-NLRP3 inflammasome pathway.
Shan X; Tao W; Li J; Tao W; Li D; Zhou L; Yang X; Dong C; Huang S; Chu X; Zhang C
J Ethnopharmacol; 2024 Jul; 329():118145. PubMed ID: 38582153
[TBL] [Abstract][Full Text] [Related]
4. Kai-Xin-San protects against mitochondrial dysfunction in Alzheimer's disease through SIRT3/NLRP3 pathway.
Su S; Chen G; Gao M; Zhong G; Zhang Z; Wei D; Luo X; Wang Q
Chin Med; 2023 Mar; 18(1):26. PubMed ID: 36918872
[TBL] [Abstract][Full Text] [Related]
5. Icarisid II rescues cognitive dysfunction via activation of Wnt/β-catenin signaling pathway promoting hippocampal neurogenesis in APP/PS1 transgenic mice.
Xiao HH; Chen JC; Li H; Li RH; Wang HB; Song HP; Li HY; Shan GS; Tian Y; Zhao YM; Tian JM; Yang JX
Phytother Res; 2022 May; 36(5):2095-2108. PubMed ID: 35230733
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA regulates glycogen synthase kinase-3β-related signaling pathway and ameliorates memory impairment in APP/PS1 transgenic mice.
Peng X; Chen L; Wang Z; He Y; Ruganzu JB; Guo H; Zhang X; Ji S; Zheng L; Yang W
Eur J Pharmacol; 2022 Mar; 918():174772. PubMed ID: 35090935
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Mechanism of Kai Xin San on Alzheimer's Disease Based on Network Pharmacology and Experimental Validation.
Wang K; Yang R; Chen TT; Qin MR; Wang P; Kong MW
Chin J Integr Med; 2023 May; 29(5):413-423. PubMed ID: 36474082
[TBL] [Abstract][Full Text] [Related]
8. Exploring the anti-ferroptosis mechanism of Kai-Xin-San against Alzheimer's disease through integrating network pharmacology, bioinformatics, and experimental validation strategy in vivo and in vitro.
Yan C; Yang S; Shao S; Zu R; Lu H; Chen Y; Zhou Y; Ying X; Xiang S; Zhang P; Li Z; Yuan Y; Zhang Z; Wang P; Xie Z; Wang W; Ma H; Sun Y
J Ethnopharmacol; 2024 May; 326():117915. PubMed ID: 38360383
[TBL] [Abstract][Full Text] [Related]
9.
Xu YM; Wang XC; Xu TT; Li HY; Hei SY; Luo NC; Wang H; Zhao W; Fang SH; Chen YB; Guan L; Fang YQ; Zhang SJ; Wang Q; Liang WX
Neural Regen Res; 2019 May; 14(5):794-804. PubMed ID: 30688265
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rg1 improves Alzheimer's disease by regulating oxidative stress, apoptosis, and neuroinflammation through Wnt/GSK-3β/β-catenin signaling pathway.
Yang Y; Wang L; Zhang C; Guo Y; Li J; Wu C; Jiao J; Zheng H
Chem Biol Drug Des; 2022 Jun; 99(6):884-896. PubMed ID: 35313087
[TBL] [Abstract][Full Text] [Related]
11. Kai-Xin-San Attenuates Doxorubicin-Induced Cognitive Impairment by Reducing Inflammation, Oxidative Stress, and Neural Degeneration in 4T1 Breast Cancer Mice.
Lyu W; Ouyang M; Ma X; Han T; Pi D; Qiu S
Evid Based Complement Alternat Med; 2021; 2021():5521739. PubMed ID: 34234834
[TBL] [Abstract][Full Text] [Related]
12. L-3-n-butylphthalide Rescues Hippocampal Synaptic Failure and Attenuates Neuropathology in Aged APP/PS1 Mouse Model of Alzheimer's Disease.
Zhang Y; Huang LJ; Shi S; Xu SF; Wang XL; Peng Y
CNS Neurosci Ther; 2016 Dec; 22(12):979-987. PubMed ID: 27439966
[TBL] [Abstract][Full Text] [Related]
13. [Effect of Huanglian Jiedu Decoction on TREM2/Akt/GSK3β pathway in cerebral cortex of APP/PS1 transgenic mice].
Wang RF; Song JY; Zhao HD; Jia YQ; Yuan Y; Ding R; Wang MF; Zhang ZQ
Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(7):1924-1931. PubMed ID: 38812205
[TBL] [Abstract][Full Text] [Related]
14. Kai-Xin-San Inhibits Tau Pathology and Neuronal Apoptosis in Aged SAMP8 Mice.
Jiao YN; Zhang JS; Qiao WJ; Tian SY; Wang YB; Wang CY; Zhang YH; Zhang Q; Li W; Min DY; Wang ZY
Mol Neurobiol; 2022 May; 59(5):3294-3309. PubMed ID: 35303280
[TBL] [Abstract][Full Text] [Related]
15. 3,6'-Disinapoyl sucrose alleviates cognitive deficits in APP/PS1 transgenic mice.
Yuan J; He M; Dai X; Huo Q; Chang P; Zhang J; Wang S; Sun Y
J Neurophysiol; 2023 Nov; 130(5):1174-1182. PubMed ID: 37702542
[TBL] [Abstract][Full Text] [Related]
16. Roflumilast ameliorates cognitive impairment in APP/PS1 mice via cAMP/CREB/BDNF signaling and anti-neuroinflammatory effects.
Feng H; Wang C; He W; Wu X; Li S; Zeng Z; Wei M; He B
Metab Brain Dis; 2019 Apr; 34(2):583-591. PubMed ID: 30610438
[TBL] [Abstract][Full Text] [Related]
17. Kai-xin-san improves cognitive impairment in D-gal and Aβ
Wang H; Zhou L; Zheng Q; Song Y; Huang W; Yang L; Xiong Y; Cai Z; Chen Y; Yuan J
J Ethnopharmacol; 2024 Jul; 329():118161. PubMed ID: 38599474
[TBL] [Abstract][Full Text] [Related]
18. Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer's disease via inhibiting neuropathology and modulating gut microbiota.
Qu C; Li QP; Su ZR; Ip SP; Yuan QJ; Xie YL; Xu QQ; Yang W; Huang YF; Xian YF; Lin ZX
J Adv Res; 2022 Jan; 35():231-243. PubMed ID: 35024199
[TBL] [Abstract][Full Text] [Related]
19. Rapid discovery of quality-markers from Kaixin San using chinmedomics analysis approach.
Wang XJ; Zhang AH; Kong L; Yu JB; Gao HL; Liu ZD; Sun H
Phytomedicine; 2019 Feb; 54():371-381. PubMed ID: 30322673
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics approach to explore the effects of Kai-Xin-San on Alzheimer's disease using UPLC/ESI-Q-TOF mass spectrometry.
Chu H; Zhang A; Han Y; Lu S; Kong L; Han J; Liu Z; Sun H; Wang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1015-1016():50-61. PubMed ID: 26896572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
